You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

R912P

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19, SARS-CoV-2 Trial in Johannesburg, Pretoria (GRT-R912, samRNA-Spikebeta-TCE11, GRT-R914, samRNA-Spikebeta-TCE9,

Recruiting
  • COVID-19
  • SARS-CoV-2
  • GRT-R912, samRNA-Spikebeta-TCE11
  • +2 more
  • Johannesburg, South Africa
  • +1 more
Jun 24, 2022

Heart Failure With Preserved Ejection Fraction Trial in Porto (Dapagliflozin, Spironolactone, Spironolactone + Dapagliflozin)

Recruiting
  • Heart Failure With Preserved Ejection Fraction
  • Porto, Portugal
  • +1 more
Jan 12, 2023

Schistosomiasis Trial in Seattle (Sm-p80, Sm-p80 + GLA-SE)

Recruiting
  • Schistosomiasis
  • Sm-p80
  • Sm-p80 + GLA-SE
  • Seattle, Washington
    Kaiser Permanente Washington Health Research Institute - Vaccine
Sep 21, 2022

Genomics of Primary Sclerosing Cholangitis (PSC)

Active, not recruiting
  • Primary Sclerosing Cholangitis (PSC)
  • Genetic Analysis
  • Rochester, Minnesota
    Mayo Clinic
Jan 9, 2023

Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, NSCLC Trial (ELI-002 7P)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +14 more
  • ELI-002 7P
  • (no location specified)
Feb 3, 2023

Musculoskeletal Disorder Trial in Columbus (LiftKit)

Enrolling by invitation
  • Musculoskeletal Disorder
  • LiftKit
  • Columbus, Ohio
    The Ohio State University
Sep 19, 2022

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial in Kunming (Anti-GPRC5D CAR-T cells infusion)

Recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • Anti-GPRC5D CAR-T cells infusion
  • Kunming, Yunnan, China
  • +1 more
Feb 21, 2023

Ataxia, Degenerative Disease, Genetic Disease Trial in Saint-Didier-au-Mont-d'Or, Saint-Genis-Laval, Saint-Étienne (PAMPERO

Not yet recruiting
  • Ataxia
  • +2 more
  • PAMPERO program
  • Saint-Didier-au-Mont-d'Or, France
  • +2 more
Oct 17, 2023

Diffuse Large B Cell Lymphoma Trial in Wuhan (Zanubrutinib plus RCHOP)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Zanubrutinib plus RCHOP
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Aug 16, 2023

IGF1R And p95HER2 as Prognostic Factors in Non Small Cell Lung

Completed
  • Non Small Cell Lung Cancer
  • Protein expression by immunohistochemistry and immunofluorescence
  • Rozzano, Milan, Italy
    Istituto Clinco Humanitas
Sep 8, 2022

DLBCL Trial in Qingdao (Selinexor combined with Prednisone, Etoposide, and Lenalidomide)

Not yet recruiting
  • DLBCL
  • Selinexor combined with Prednisone, Etoposide, and Lenalidomide
  • Qingdao, Shandong, China
    the affiliated hospital of Qingdao University
Aug 18, 2022

Osteoporosis, Postmenopausal Trial in Port Saint Lucie (TVB-009, Prolia®)

Active, not recruiting
  • Osteoporosis, Postmenopausal
  • TVB-009
  • Prolia®
  • Port Saint Lucie, Florida
    Site 10101
Feb 1, 2023

Dementia Trial in Oakville, Toronto (Immersive VR Therapy in Head-Mounted Device (HMD))

Not yet recruiting
  • Dementia
  • Immersive VR Therapy in Head-Mounted Device (HMD)
  • Oakville, Ontario, Canada
  • +3 more
May 10, 2023

Smoking, Tobacco Trial in Belfast (P1R stick, P1M stick, CIG)

Recruiting
  • Smoking, Tobacco
  • P1R stick
  • +2 more
  • Belfast, United Kingdom
    Celerion
Mar 16, 2023

Healthy Trial in Nottingham (BI 685509 oral formulation prototypes, BI 685509 standard oral formulation)

Completed
  • Healthy
  • R1: Reference Product X
  • +12 more
  • Nottingham, United Kingdom
    Quotient Sciences
Dec 7, 2022

Cervical Cancer Trial in Wuhan (Cadonilimab, Anlotinib)

Recruiting
  • Cervical Cancer
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Apr 5, 2023

Healthy Trial (Tramadol Hydrochloride 5 MG/ML Oral Solution, Tramadol Hydrochloride 100 MG/ML Oral Solution (Contramal(r)))

Not yet recruiting
  • Healthy
  • Tramadol Hydrochloride 5 MG/ML Oral Solution
  • Tramadol Hydrochloride 100 MG/ML Oral Solution (Contramal(r))
  • (no location specified)
Feb 6, 2023

Chronic Venous Disease, Chronic Insufficiency Venous Trial in Czechia (Vessel, Placebo)

Recruiting
  • Chronic Venous Disease
  • Chronic Insufficiency Venous
  • Hodonín, Jihomoravský Kraj, Czechia
  • +14 more
Apr 13, 2022

IRD at Admission Predicts Survival of GBM Patients -Prospective

Recruiting
  • Glioblastoma Multiforme
    • Winnipeg MB, Manitoba, Canada
    • +1 more
    Jun 8, 2022

    Prevention, Type2Diabetes Trial in Winnipeg (Dialectical behavioral therapy, Lifestyle)

    Active, not recruiting
    • Prevention
    • Type2Diabetes
    • Dialectical behavioral therapy
    • Lifestyle
    • Winnipeg, Manitoba, Canada
      University of Manitoba
    Feb 2, 2023

    Perimenopause, Sexual Concerns Trial in Hamilton (Cognitive Behavioural Therapy)

    Recruiting
    • Perimenopause
    • Sexual Concerns
    • Cognitive Behavioural Therapy
    • Hamilton, Ontario, Canada
      St. Joseph's Healthcare Hamilton
    Aug 22, 2022

    Mobocertinib in Adults With Lung Cancer in China (MEANING)

    Not yet recruiting
    • Non-small Cell Lung Cancer (NSCLC)
    • No Intervention
    • Shanghai, China
      Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai J
    May 9, 2023

    MDD Trial (Low Dose 5-hydroxytryptophan, High Dose 5-hydroxytryptophan, Low Dose Creatine Monohydrate)

    Not yet recruiting
    • Major Depressive Disorder
    • Low Dose 5-hydroxytryptophan
    • +4 more
    • (no location specified)
    Jun 8, 2023

    Cardiovascular Diseases, Type2diabetes Trial in Winnipeg (Peer mentorship and physical activity)

    Not yet recruiting
    • Cardiovascular Diseases
    • Type2diabetes
    • Peer mentorship and physical activity
    • Winnipeg, Manitoba, Canada
      University of Manitoba
    Feb 10, 2023

    Metastatic Colorectal Cancer Trial in Italy (Cetuximab, Avelumab)

    Recruiting
    • Metastatic Colorectal Cancer
    • Ancona, Italy
    • +23 more
    Oct 25, 2022